This study aimed to evaluate the efficacy of N-acetylcysteine (NAC) used as an intracanal medicament on antibacterial activity, periapical RANKL/OPG ratio, and postoperative pain levels.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Non-vital teeth confirmed by clinical and pulp sensitivity tests
* Teeth with a single canal and diagnosed with asymptomatic apical periodontitis
* Periapical assessment (PAI) of 2 or greater
* Teeth with a pocket depth not exceeding 3 mm
* Teeth without excessive root curvature (Schneider class 1) and with visible root canals on radiographs
* Permanent teeth with complete root development
* Patients between the ages of 18 and 65
* Teeth without previous endodontic treatment
Exclusion Criteria:
* Patients who refused to participate in the study
* Patients with any systemic disease
* Patients who received antibiotic treatment within the last 3 months
* Patients who were pregnant or suspected of being pregnant
* Teeth with excessive crown damage that would not allow for the placement of a rubber dam
* Teeth with root fractures, pathological findings or mobility,
* Presence of any resorption in the involved tooth,
* Patients with active swelling and tenderness to palpation.
What they're measuring
1
Antibacterial efficacy of intracanal medicaments, RANKL/OPG ratio and effect on postoperative pain
Timeframe: The medication will remain in the canal for one week. Patients will receive treatment within one month.